TRISH, which is led by Baylor College of Medicine in Houston, applies emerging biomedical advances on the ground to space health. Its academic partners include Pasadena-based California Institute of Technology and Cambridge-based Massachusetts Institute of Technology.
The consortium’s mission is to promote health technologies that “predict, protect and preserve astronaut health during deep space exploration missions,” according to the call for proposals, which outlined six topics of interest.
1. Algorithms that predict health, behavior and medical events
2. Nucleotide-based therapies that improve resilience
3. Non-pharmacological solutions that improve human performance
4. Multipurpose edible plants related to various spaceflight applications
5. New materials for shielding medications
6. Solutions to test for expired medications
The first phase of applications is due April 16. TRISH will invite a second phase of applicants to complete a more detailed proposal by June 25.
Applicants who clear the second round will receive awards of up to $400,000 in funding per year for a maximum of two years.
To access TRISH’s call for proposals, click here.
More articles on health IT:
Almost half of physicians ‘aren’t aware’ of what blockchain is
Data from Geisinger’s biobank fuels discovery of potential liver disease treatment
4 health IT leaders weigh in on cloud, disruptors and employee retention
